Brief introduction of Jilin Aodong Pharmaceutical Group Co., Ltd.

By the end of 20 12, the total share capital of the company was 894,438,400 shares, the audited total assets were10961469,600 yuan, the net assets were 967,230,200 yuan, and the asset-liability ratio was11.76. 20 12 annual sales revenue1445,463,200 yuan, total profit of 682,578,600 yuan and net profit of 646417,200 yuan.

Company 1998 has been recognized as a national technology center by the State Economic and Trade Commission, which has become the main technical support for technological progress and innovation of enterprises. 200165438+February1kloc-0/The Ministry of Personnel approved the establishment of postdoctoral workstations. During the Tenth Five-Year Plan period, Jilin Aodong National Technology Center will be built into a new technology research and development center, a Industry-University-Research cooperation and exchange center and a technology decision-making consultation center. In 2002, the company was approved by the Ministry of Agriculture and other nine ministries and commissions as a national key leading enterprise in agricultural industrialization; In September 2003, it was awarded "Excellent High-tech Enterprise of Torch Program" by the Ministry of Science and Technology. In June, 2002, it was rated as a model enterprise of modern science and technology industrial base of traditional Chinese medicine. In April, 2007, it won the National May 1st Labor Award, and was once again rated as the key leading enterprise of agricultural industrialization by nine ministries and commissions including the Ministry of Agriculture. In June, 2008, 5438+ 10 was awarded as a demonstration unit of enterprise informatization in Jilin Province, and won the honors of A-level tax paying enterprise, AAA-level bank credit rating, and Jilin Province's contract-abiding and credit-abiding unit for many years. From June, 5438 to February, 2009, it won the 16th national first-class enterprise management modernization innovation achievement.

After decades of development, the company has built four core competitiveness: the management team with one heart and one mind, the advanced technology leading the modernization of Chinese medicine, the brand sail without wind and self-promotion, and the authentic raw material base of Changbai Mountain. The trademark "Aodong" 1999 has been recognized as a well-known trademark in China by the State Administration for Industry and Commerce, and has won the title of "China 500 Most Valuable Brands" for six consecutive years. The company's leading products, Anshen Bunao Liquid, Xuefu Zhuyu Oral Liquid, Linaoxin Capsule and Xinnaoshutong Capsule, have kept the title of provincial excellent, ministerial excellent and China famous brand products for many years. Lutai Granule, Shaofu Zhuyu Granule, Xiaoer Chaigui Oral Liquid, Yangxueyin Oral Liquid, Jinqi Jiangtang Capsule, Jin Lianhua Oral Liquid, Zhen Shi Burn Ointment, Sangju Ganmao Granule, Anshen Bunao Soft Capsule, Xiaokening Tablet, Gandakang Capsule and Yihechun Capsule. Compound Yiganling Tablets, Qingnaozhitong Capsules, Radix Isatidis Granules, Hepatic Hydrolysate Peptide Injection, Guanfu A Hydrochloride Injection, Shengmai Drink, Acetylglutamine Injection, Sodium Ozagrel for Injection, Yuxintong Capsules, Yun Kang Granules, Danxiang Qingzhi Granules, etc.

The company will continue to implement the policy of "strengthening refined production management, deepening the reform of marketing system, adjusting the direction of product research and development, promoting the construction of information network, improving the assessment of business objectives, and enhancing the comprehensive strength of enterprises", creating greater value for shareholders, taking into account the interests of consumers, employees, creditors, suppliers and other related parties, and making contributions to social and economic development.